MANKIND - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 2.3
Show all parameters (20 more)
🧾 Trade Setup
Aggressive entry recommended. Buy at 2,305 ₹ – this provides a buffer against immediate intraday weakness. Initial exit level should be set at 2,360 ₹ for a 2% profit target, backed by the recent high of 2,674 ₹. A stop-loss order should be placed immediately at 2,280 ₹ to limit downside risk if momentum falters – this is highly sensitive given the overvaluation.
✅ Positive
High volume today (5.65M) suggests significant interest, and the recent DII increase (0.93%) indicates some buying pressure. The Q2 profit surge (558 Cr.) compared to the previous quarter’s 732 Cr., while a decline, is still positive, and the stock has recently traded near its high of 2,674 ₹.
⚠️ Limitation
The extremely elevated P/E ratio of 42.1 versus the industry average of 34.8 suggests significant overvaluation – this leaves little margin for error if sentiment shifts. Furthermore, the negative MACD (-41.4) indicates a weakening momentum and potential downward pressure as the market opens.
📉 Company Negative News
Univest reports suggest Mankind Pharma is facing price drops, indicating a cautious approach from investors despite earnings growth.
📈 Company Positive News
The Q2 profit surge of 558 Cr. exceeded some analyst expectations, contributing to limited selling pressure today.
🏭 Industry
Pharmaceuticals are generally considered defensive but have recently seen significant volatility due to regulatory changes and competition; a strong earnings report can provide a temporary boost, however.